Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients

被引:70
作者
Pergam, S. A. [1 ,2 ]
Forsberg, C. W. [3 ]
Boeckh, M. J. [1 ,2 ]
Maynard, C. [3 ,4 ]
Limaye, A. P. [1 ,5 ]
Wald, A. [1 ,2 ,5 ,6 ]
Smith, N. L. [3 ,6 ]
Young, B. A. [1 ,3 ,7 ]
机构
[1] Univ Washington, Dept Med, Seattle, WA USA
[2] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA
[3] Vet Affairs Puget Sound Hlth Care Syst, Epidemiol Res & Informat Ctr, Seattle, WA USA
[4] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA
[5] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
[6] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[7] Vet Affairs Puget Sound Hlth Care Syst, Dept Med, Seattle, WA USA
关键词
herpes zoster; infection; liver transplantation; kidney transplantation; African American; VARICELLA-ZOSTER; RENAL-TRANSPLANTATION; INFECTIOUS COMPLICATIONS; LIVER-TRANSPLANTATION; RACIAL-DIFFERENCES; GRAFT-SURVIVAL; UNITED-STATES; RISK-FACTORS; VETERANS; AFFAIRS;
D O I
10.1111/j.1399-3062.2010.00547.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Immunosuppressed patients are at increased risk for herpes zoster (HZ), but incidence in solid organ transplant (SOT) recipients has varied in multiple studies. To assess incidence of HZ, we examined patients who underwent SOT and received follow-up care within the large multicenter US Department of Veteran's Affairs healthcare system. Methods Incident cases of HZ were determined using ICD-9 coding from administrative databases. A multivariable Cox proportional hazards model, adjusted for a priori risk factors, was used to assess demographic factors associated with development of HZ. Results Among the 1077 eligible SOT recipients, the cohort-specific incidence rate of HZ was 22.2 per 1000 patient-years (95% confidence interval [CI], 18.1-27.4). African Americans (37.6 per 1000 [95% CI, 25.0-56.6]) and heart transplants recipients (40.0 per 1000 [95% CI, 23.2-68.9]) had the highest incidence of HZ. Patients transplanted between 2005 and 2007 had the lowest incidence (15.3 per 1000 [95% CI, 8.2-28.3]). In a multivariable model, African Americans (hazard ratio [HR] 1.88; 95% CI: 1.12, 3.17) and older transplant recipients (HR 1.13; 95% CI: 1.01, 1.27 [per 5-year increment]) had increased relative hazards of HZ. Conclusions These data demonstrate that HZ is a common infectious complication following SOT. Future studies focused on HZ prevention are needed in this high-risk population.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 69 条
[1]  
Ahsan N, 1999, TRANSPLANTATION, V68, P1865
[2]   Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis [J].
Arness, T. ;
Pedersen, R. ;
Dierkhising, R. ;
Kremers, W. ;
Patel, R. .
TRANSPLANT INFECTIOUS DISEASE, 2008, 10 (04) :260-268
[3]   Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation [J].
Asano-Mori, Yuki ;
Kanda, Yoshinobu ;
Shima, Kumi ;
Kako, Shinichi ;
Shinohara, Akihito ;
Nakasone, Hideki ;
Sato, Hiroyuki ;
Watanabe, Takuro ;
Hosoya, Noriko ;
Izutsu, Koji ;
Asai, Takashi ;
Hangaishi, Akira ;
Motokura, Toru ;
Chiba, Shigeru ;
Kurokawa, Mineo .
AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (06) :472-476
[4]   Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7 metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid [J].
Bernard, Olivier ;
Tojcic, Jelena ;
Journault, Kim ;
Perusse, Louis ;
Guillemette, Chantal .
DRUG METABOLISM AND DISPOSITION, 2006, 34 (09) :1539-1545
[5]  
Boeckh Michael, 2006, Herpes, V13, P60
[6]   Dual use of VA and non-VA primary care [J].
Borowsky, S ;
Cowper, DC .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1999, 14 (05) :274-280
[7]  
BREUER J, 2004, PRINCIPLES PRACTICE, V2, P53
[8]   IMMUNE-RESPONSES TO VARICELLA-ZOSTER IN THE AGED [J].
BURKE, BL ;
STEELE, RW ;
BEARD, OW ;
WOOD, JS ;
CAIN, TD ;
MARMER, DJ .
ARCHIVES OF INTERNAL MEDICINE, 1982, 142 (02) :291-293
[9]   Ethnicity as a predictor of graft longevity and recipient mortality in heart transplantation [J].
Cohen, O. ;
De La Zerda, D. ;
Beygui, R. E. ;
Hekmat, D. ;
Laks, H. .
TRANSPLANTATION PROCEEDINGS, 2007, 39 (10) :3297-3302
[10]  
*DEP HLTH HUM SER, 2007 ANN REP US OR P